Publisher Correction: Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')
2
fragments
Sci Rep
.
2023 Sep 18;13(1):15419.
doi: 10.1038/s41598-023-42526-y.
Authors
Stephen Findlay-Wilson
1
,
Linda Easterbrook
1
,
Sandra Smith
2
,
Neville Pope
3
,
Matthew Aldridge
4
,
Gareth Humphries
5
,
Holger Schuhmann
5
,
Didier Ngabo
1
,
Emma Rayner
1
,
Ashley Otter
1
,
Thomas Coleman
1
,
Bethany Hicks
1
,
Rachel Halkerston
1
,
Kostis Apostolakis
1
,
Stephen Taylor
1
,
Susan Fotheringham
1
,
Amanda Horton
1
,
Irene CanoCejas
1
,
Matthew Wand
1
,
Julia A Tree
1
,
Mark Sutton
1
,
Victoria Graham
1
,
Roger Hewson
1
,
Stuart Dowall
6
Affiliations
1
UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
2
International Therapeutic, Proteins Ltd, Longford, TAS, 7301, Australia.
3
International Therapeutic Proteins Ltd, Goleigh Farm, Hampshire, Selborne, GU34 3SE, UK.
4
MicroPharm Ltd, Station Road, Newcastle Emlyn, SA38 9BY, UK.
5
Native Antigen Company, Langford Locks, Kidlington, Oxford, OX5 1LH, UK.
6
UK Health Security Agency (UKHSA), Porton Down, Salisbury, Wiltshire, SP4 0JG, UK. stuart.dowall@ukhsa.gov.uk.
PMID:
37723274
PMCID:
PMC10507104
DOI:
10.1038/s41598-023-42526-y
No abstract available
Publication types
Published Erratum